The detection of BMPR1A was expected to be more sensitive and specific than the detection of PLAC8 gene methylation in patients with hepatocellular carcinoma recurrence, and PLAC8 methylation is expected to be a method that can be used to monitor the recurrence of hepatocellular carcinoma. This evidence concerns the gene BMPR1A and hepatocellular carcinoma.